Letter to the Editor: Limitations of acetylcholinesterase inhibitor therapy for Alzheimer’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter to the Editor: Limitations of acetylcholinesterase inhibitor therapy for Alzheimer’s disease

Published:2024-05-10 Issue:9 Volume:110 Page:5852-5853
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Yang Guang¹,Wu Jiawen¹,Lei Hang²,Hui Yining³

Affiliation:

1. Department of Neurology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan

2. Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan

3. Southwest Medical University, Luzhou, People’s Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference4 articles.

1. Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer’s disease;Zuliani;Aging Clin Exp Res,2024

2. The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs;Zhang;Int J Surg (London, England),2024

3. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives;Moreira;J Alzheimers Dis Rep,2022

4. Uncovering the impact of aggrephagy in the development of Alzheimer’s disease: insights into diagnostic and therapeutic approaches from machine learning analysis;Xu;Curr Alzheimer Res,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP